» Articles » PMID: 32510467

Crystal Structure of the SH3 Domain of Growth Factor Receptor-bound Protein 2

Overview
Specialty Chemistry
Date 2020 Jun 9
PMID 32510467
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

This study presents the crystal structure of the N-terminal SH3 (SH3N) domain of growth factor receptor-bound protein 2 (Grb2) at 2.5 Å resolution. Grb2 is a small (215-amino-acid) adaptor protein that is widely expressed and involved in signal transduction/cell communication. The crystal structure of full-length Grb2 has previously been reported (PDB entry 1gri). The structure of the isolated SH3N domain is consistent with the full-length structure. The structure of the isolated SH3N domain was solved at a higher resolution (2.5 Å compared with 3.1 Å for the previously deposited structure) and made it possible to resolve some of the loops that were missing in the full-length structure. In addition, interactions between the carboxy-terminal region of the SH3N domain and the Sos1-binding sites were observed in the structure of the isolated domain. Analysis of these interactions provided new information about the ligand-binding properties of the SH3N domain of Grb2.

Citing Articles

Trimethylamine N-oxide (TMAO) doubly locks the hydrophobic core and surfaces of protein against desiccation stress.

Ru G, Liu X, Ge Y, Wang L, Jiang L, Pielak G Protein Sci. 2024; 33(8):e5107.

PMID: 38989549 PMC: 11237552. DOI: 10.1002/pro.5107.


The Configuration of GRB2 in Protein Interaction and Signal Transduction.

Wang D, Liu G, Meng Y, Chen H, Ye Z, Jing J Biomolecules. 2024; 14(3).

PMID: 38540680 PMC: 10968029. DOI: 10.3390/biom14030259.


The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia.

Liu Y, Jang H, Zhang M, Tsai C, Maloney R, Nussinov R Biophys J. 2022; 121(12):2251-2265.

PMID: 35651316 PMC: 9279350. DOI: 10.1016/j.bpj.2022.05.030.


Modeling a unit cell: crystallographic refinement procedure using the biomolecular MD simulation platform .

Mikhailovskii O, Xue Y, Skrynnikov N IUCrJ. 2022; 9(Pt 1):114-133.

PMID: 35059216 PMC: 8733891. DOI: 10.1107/S2052252521011891.

References
1.
Winn M, Ballard C, Cowtan K, Dodson E, Emsley P, Evans P . Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):235-42. PMC: 3069738. DOI: 10.1107/S0907444910045749. View

2.
Nishio M, Umezawa Y, Fantini J, Weiss M, Chakrabarti P . CH-π hydrogen bonds in biological macromolecules. Phys Chem Chem Phys. 2014; 16(25):12648-83. DOI: 10.1039/c4cp00099d. View

3.
Anand K, Pal D, Hilgenfeld R . An overview on 2-methyl-2,4-pentanediol in crystallization and in crystals of biological macromolecules. Acta Crystallogr D Biol Crystallogr. 2002; 58(Pt 10 Pt 1):1722-8. PMC: 7161645. DOI: 10.1107/s0907444902014610. View

4.
Saksela K, Permi P . SH3 domain ligand binding: What's the consensus and where's the specificity?. FEBS Lett. 2012; 586(17):2609-14. DOI: 10.1016/j.febslet.2012.04.042. View

5.
Afonine P, Grosse-Kunstleve R, Echols N, Headd J, Moriarty N, Mustyakimov M . Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr. 2012; 68(Pt 4):352-67. PMC: 3322595. DOI: 10.1107/S0907444912001308. View